Northwest up 17% premarket


Shares of Nothwest Biotherapeutics (NWBO) are poised for a gap up this morning. CEO Linda Powers is slated to present DCVax data at a cancer immunotherapy conference today at 2:45 pm ET.

The company sparred recently with The Street's Adam Feuerstein over its disclosures regarding DCVax approval in Germany.

Analysts expect the firm to post $2.9M in revenues this year.

From other sites
Comments (7)
  • alext1379
    , contributor
    Comments (759) | Send Message
     
    Gains are premature for just speaking at a conference. I've followed this stock from sub $5 and know it spikes and drops for little or no real reason.

     

    Unless there is good news to come today, it will fall back. The price runup happened within 15 min so I believe it was automated trading or people who know nothing about the company or the history (which leads me to believe Furstein may have bought shares in PM).
    27 Mar 2014, 09:25 AM Reply Like
  • tinsley09
    , contributor
    Comments (339) | Send Message
     
    Unless you want to assume that Linda Powers of NWBO is delusional or psychotic,she would not schedule a major announcement, at short notice at the prestigious New York Academy of Sciences(Academy of Medicine).Clearly she has something cogent and credible to report.This is congruent with NWBO's expanded space purchase at the upcoming convention on academic and clinical immunology in May 2014.
    27 Mar 2014, 09:40 AM Reply Like
  • alext1379
    , contributor
    Comments (759) | Send Message
     
    I hope you are correct. I've been sitting on shares since $4.85 and would like to see them visit and stay at double digits again.
    27 Mar 2014, 09:50 AM Reply Like
  • budfish
    , contributor
    Comments (68) | Send Message
     
    tinsley09, I agree that Linda is a savy leader of NWBO and IMHO has acted in the best interest of NWBO shareholders at every step. As a holder of the stock, call options, and warrants from as far back as 2010 it has been a ride to behold and I really feel sure Management has confidence the treatment strategy not only works but with the production infrastructure NWBO has built it will be marketable worldwide at a price that produces a huge bottom line.
    27 Mar 2014, 10:15 AM Reply Like
  • BBKing20013
    , contributor
    Comments (5) | Send Message
     
    A big surprise coming enjoyed boys!
    27 Mar 2014, 10:15 AM Reply Like
  • BBKing20013
    , contributor
    Comments (5) | Send Message
     
    We should see a very positive outlook and some surprises!
    27 Mar 2014, 10:15 AM Reply Like
  • tinsley09
    , contributor
    Comments (339) | Send Message
     
    Information from several divergent sources(production infrastructure,space purchase at basic and applied science meeting,validation of biotechnology by German FDA,etc) is converging on a hypothesis of increasing credibility ,the basic science of dendritic cell technology is about to be validated in in the clinical domain.
    27 Mar 2014, 10:36 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs